Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
The US FDA has updated its guidance on Alzheimer's, focusing on changes in biomarkers and leadership. Additionally, the FDA and OHRP have jointly issued draft guidance on consent forms for research participants. The FDA has also released draft guidance on informed consent and new dietary ingredient notification procedures.
FDA Releases Draft Guidance on New Dietary Ingredient Notification Procedures, Timelines https://t.co/y91zsXiDxL #dietarysupplement #ingredients #ndi @EpsteinBecker https://t.co/rZy2phyJd1
In late 2023, the FDA finalized a guidance on medical device cybersecurity – but promised updates to address certain statutory requirements. Recently, the agency published a draft version of those “select updates”, read more: https://t.co/lxrfZSIQwg #AgencyIQ #Politico #FDA https://t.co/AFQTQLnIjs
Also this ... #pinksheet #Pharma: How Did US FDA Get Octapharma To Drop Its Suit? https://t.co/iWfcYbY7ur